TLR4 has been indicated to be involved in the pathological mechanisms of ALS disease, and blocking TLR4 with an antagonist extended the survival of the mSOD1 mice model (Lee et al., 2015). This evidence concerns the gene TLR4 and amyotrophic lateral sclerosis.